Actividad de albendazol y los aceites esenciales de menta (Mentha piperita) y manzanilla (Matricaria chamomilla) frente Anisakis tipo I

  1. María del Carmen Romero López 1
  2. María Concepción Navarro Moll 1
  3. Joaquina Martín Sánchez 1
  4. Adela Valero López 1
  1. 1 Universidad de Granada, España
Journal:
Ars pharmaceutica

ISSN: 2340-9894 0004-2927

Year of publication: 2014

Volume: 55

Issue: 1

Pages: 45-49

Type: Article

More publications in: Ars pharmaceutica

Abstract

Aim: We have studied the possible synergistic activity of the essential oils of Mentha piperita and Matricaria chamomile against Anisakis type I. Materials and methods: the larvicidal activity of the mixture of essential oils was tested in vitro and in vivo, using as a reference the drug Albendazole and effectiveness measured through a statistical model. Results: The in vitro and in vivo experiments both evidenced that the larvicidal activity of essential oils, was higher than the Albendazole activity. In the in vitro assay, at concentrations of 250 and 187.5 µg/ml, the mortality was 100% with the mixture of essential oils while albendazole was ineffective at the concentrations studied. In the in vivo assay, the mixture of essential oils, was significantly more effective in the reduction of numbers of lesions with rats in comparison to albendazole treatments and control. Albendazole did not significantly reduce the percentage of lesions caused by larvae vs. control. Conclusion: Considering the results, we have come to the conclusion that the mixture of peppermint essential oils and chamomile could be used in the treatment/prophylaxis of human Anisakis.

Bibliographic References

  • Muraoka A, Suehiro I, Fujii M, Nagata K, Kusunoki H, Kumon Y, et al. Acute gastric anisakiasis: 28 cases during the last 10 years. Dig Dis Sci. 1996; 41(12):2362-2365.
  • Filauro M, Rollandi GA, Cassola G, Quilici P, Angelini G, Belli F, et al. Gastrointestinal bleeding due to suspected anisakiasis: challenging differential diagnosis for a rare disease. Updates Surg. 2011; 63(3):213-217.
  • Hierro I, Valero A, Perez P, Gonzalez P, Cabo MM, Montilla MP, et al. Action of different monoterpenic compounds against Anisakis simplex s.l. L3 larvae. Phytomed. 2004; 11(1):77-82.
  • Navarro-Moll MC, Romero MC, Montilla MP, Valero A. In vitro and in vivo activity of three sesquiterpenes against L3 larvae of Anisakis type I. Exp Parasitol. 2011; 127(2):405-408.
  • Romero M, Valero López A. Actividad in vivo del mentol frente a larvas L3 de Anisakis tipo I. Ars Pharm. 2010; 51(3):841-846.
  • Romero MC, Valero A, Martin-Sanchez J, Navarro-Moll MC. Activity of Matricaria chamomilla essential oil against anisakiasis. Phytomed. 2012; 19(6):520-523.
  • Real Farmacopea Española. Agencia Española del Medicamento. Ministerio de Sanidad y Consumo. 2005.
  • Moore DA, Girdwood RW, Chiodini PL. Treatment of anisakiasis with albendazole. Lancet. 2002; 360(9326):54.
  • Ruckebusch Y. Données numériques et miscellanées. Physiologie pharmacologie thérapeutique animales. París: Maloine S.M.; 1977.
  • Zúñiga JM, Orellana JM, Tur JA. Ciencia y Tecnología del Animal de Laboratorio. Madrid: Universidad de Alcalá de Henares; 2011.
  • Zhu X, Gasser RB, Podolska M, Chilton NB. Characterisation of anisakid nematodes with zoonotic potential by nuclear ribosomal DNA sequences. Int J Parasitol. 1998; 28(12):1911-1921.
  • D’Amelio S, Mathiopoulos KD, Santos CP, Pugachev ON, Webb SC, Picanco M, et al. Genetic markers in ribosomal DNA for the identification of members of the genus Anisakis (Nematoda: ascaridoidea) defined by polymerase-chain-reaction-based restriction fragment length polymorphism. Int J Parasitol. 2000; 30(2):223-226.
  • Pontone S, Leonetti G, Guaitoli E, Mocini R, Manfredelli S, Catania A, et al. Should the host reaction to anisakiasis influence the treatment? Different clinical presentations in two cases. Rev Esp Enferm Dig. 2012; 104(11):607-610.
  • Arias-Díaz J, Zuloaga J, Vara E, Balibrea J, Balibrea JL. Efficacy of albendazole against Anisakis simplex larvae in vitro. Dig Liver Dis. 2006; 38(1):24-26.
  • Flórez J. Fármacos antiparasitarios: protozoos y helmintos. En: Flórez J, editor. Farmacología humana. Barcelona: Masson; 2003. p. 1361-1390.